FDA permits AI-powered medical device to detect diabetic eye ailment
Category: #health  By Saipriya Iyer  Date: 2018-04-12
  • share
  • Twitter
  • Facebook
  • LinkedIn

FDA permits AI-powered medical device to detect diabetic eye ailment

In what may be touted to be a highly victorious incidence in the medical devices industry, the U.S. FDA has approved the sale of an innovative medical equipment. Referred as IDx-DR, this device makes use of AI technology to detect the most common cause of vision loss witnessed among more than thirty million diabetics across the U.S.

The medical device is first of its kind to receive the nod of approval from the federal agency of the U.S. health department & human services. The product, which is manufactured by IDx LLC, offers a screening decision related to the loss of vision without the requirement of any physician for interpreting the eye images. Experts claim the product to be more useful for the doctors who interact on a regular basis with diabetics.

IDx-DR is likely to find applications in the detection of diabetic retinopathy, a medical condition during which the retina of the eye is damaged due to diabetes mellitus leading to blindness. The IDx-DR device makes use of AI system to examine the images of eye captured with the help of retinal camera. Incidentally, the system also informs the physician about the intensity of diabetic retinopathy in the patient.

In the clinical trials carried out by the FDA, IDx-DR was able to accurately determine the presence of more than mild diabetic retinopathy nearly 87.4% of the times in patients. The outcomes of the clinical trials for the diabetics proved that the medical instrument can detect patients who are not affected due to more than mild ailment nearly 89.5% of the times.

Malvina Eydelman, one of FDA officials, announced that the food & drug authority of the country will continue to facilitate access to safe and efficient digital health devices for the patients. As per reports, the review of IDx-DR was carried out by the FDA in accordance with the new regulations designed to speed up the marketing of some medical devices categorized under low and moderate risk types.



About Author

Saipriya Iyer

Email: [email protected]   

Saipriya Iyer

Saipriya Iyer develops content for Market Size Forecasters, Algosonline, and myriad other platforms. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her bel...

Read More

More News By Saipriya Iyer

Foodics enters Egypt market by setting an on-ground presence in Cairo
Foodics enters Egypt market by setting an on-ground presence in Cairo
By Saipriya Iyer

Saudi Arabia-based restaurant management platform Foodics, has announced that it has entered the Egyptian market by creating an on-the-ground presence in Cairo.  The expansion comes after the company raised USD 4 ...

Food Emulsifiers Market to Witness an Appreciable Growth By 2026
Food Emulsifiers Market to Witness an Appreciable Growth By 2026
By Saipriya Iyer

This advanced report on the Food Emulsifiers Market includes of an in-depth overview of this business sphere. Alongside, details of the present market size and status have been given. The report aims to provide substantial updates on the market, p...

Bharat Biotech reveals positive data from animal trial of Covaxin
Bharat Biotech reveals positive data from animal trial of Covaxin
By Saipriya Iyer

Bharat Biotech, an Indian biotechnology company, has reportedly revealed positive results from the animal trial of Covaxin, India’s COVID-19 vaccine candidate.

In the animal t...